Neotropix Logo.. .
         
 Home   Site Map   Search   Contact Us
About Neotropix Products Technology Partnering News and Events Careers
 

Neotropix
Investing in the Future

Need text here


Investors:

VIMAC Milestone Medica
VIMAC Milestone Medica Fund is an early stage life sciences fund co-sponsored by VIMAC Ventures LLC, RBC Technology Ventures, and BTG. The fund is the latest offering in the VIMAC Ventures family of Boson-based fund and is focused on companies along the East Coast of the U.S. and into Ontario and Quebec. Joining the co-sponsors are a number of institutional investors including The Solidarity Fund QFL, headquartered in Montreal, with more than C$5.2 billion in assets, and Innovatech Montréal, Quebec's leading high-tech venture capital investor. As a result of the strong support of these LP's, VMM has a unique focus on the Quebec life sciences community. Please visit www.vimac.com.

Quaker BioVentures
Quaker BioVentures is a $280M venture capital firm dedicated to investing in life science companies located in the Mid-Atlantic region. The firm leads investments in companies across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, health information technology, and healthcare services. Quaker BioVentures invests in companies at varying stages of development, from early stage businesses to public companies. Please visit www.quakerbio.com.

The Aurora Funds
Founded in 1994, The Aurora Funds is a venture capital firm that provides capital and strategic help to entrepreneurs with early stage life sciences and information technology companies in the Southeastern and mid-Atlantic United States. The firm has more than $155 million of total capital under management and is currently investing out of its fourth fund of $85 million. The firm has the capacity to invest between $4 million and $7 million throughout the life cycle of an investment. More information is available at www.aurorafunds.com.

© 2007 Neotropix